Funding for this research was provided by:
National Institutes of Health (R01AI132695, P01 AI077774)
U.S. Department of Agriculture (AP20VSSPRS00C143)
Received: 21 June 2021
Accepted: 30 August 2021
First Online: 15 September 2021
: R.M. is listed as an inventor in one patent related to the PMCA technology. C.S. is inventor on several patents related to the PMCA technology and is currently Founder, Chief Scientific Officer and Vice-President of Amprion Inc, a biotech company focusing on the commercial utilization of PMCA for diagnosis of various neurodegenerative diseases. F.B-R., PS, T.E., R.D., S.R., C.S.G.C., M.L. and T.N. have no conflicts to declare for this study.